Skip to main content

Triathlon Tritanium Cone Augments Outcomes Study

Active, not recruiting · Not applicable · NCT02521103

Conditions: Arthroplasty, Replacement, Knee

At a glance

Research payments reported, 2025
$42,543
U.S. investigators named
7
Sites paid
7
Planned or actual enrollment
254

About the trial

Sponsor
Stryker Orthopaedics
Tested
Triathlon Tritanium Cone Augments (device)
Dates
Started 2015-08; completion 2028-03-31
Results posted
Yes

The purpose of this study was to evaluate the success rate of the Triathlon Tritanium Cone Augment with the Triathlon TS Total Knee System at 2 years postoperative, defined as absence of revision of the Femoral Cone Augment or Tibial Cone augment for aseptic loosening.

From ClinicalTrials.gov, last updated 2026-06-01. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Stryker Corporation reported $42,543 in research payments for this study in 2025 (29 payments).

Products named: Tritanium, Triathlon

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.